• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何逃离癌症吸引子:多靶点药物的原理和局限性。

How to escape the cancer attractor: rationale and limitations of multi-target drugs.

机构信息

Institute for Systems Biology, Seattle WA, USA.

出版信息

Semin Cancer Biol. 2013 Aug;23(4):270-8. doi: 10.1016/j.semcancer.2013.06.003. Epub 2013 Jun 20.

DOI:10.1016/j.semcancer.2013.06.003
PMID:23792873
Abstract

The increasingly evident limitations of target-selective cancer therapy has stimulated a flurry of ideas for overcoming the development of resistance and recurrence - the near universal reason for therapy failure from which target-selective drugs are not exempt. A widely proposed approach to conquer therapy resistance is to depart from the myopic focus on individual causal pathways and instead target multiple nodes in the cancer cell's gene regulatory network. However, most ideas rely on a simplistic conceptualization of networks: utilizing solely their topology and treating it as a display of causal interactions, while ignoring the integrated dynamics in state space. Here, we review the more encompassing formal framework of global network dynamics in which cancer cells, like normal cell types, are high-dimensional attractor states. Then therapy is represented by the network perturbation that will promote the exit from such cancer attractors and reentering a normal attractor. We show in this qualitative and accessible discussion how the idea of a quasi-potential landscape and the theory of least-action-path offer a new formal understanding for computing the set of network nodes (molecular targets) that need to be targeted in concert in order to exit the cancer attractor. But targeting cancer cells based on the network configuration of an "average" cancer cell, however precise, may not suffice to eradicate all tumor cells because of the dynamic non-genetic heterogeneity of cancer cell populations that makes them moving targets and drives the replenishment of the cancer attractor with surviving, non-responsive cells from neighboring abnormal attractors.

摘要

日益明显的肿瘤靶向治疗局限性,刺激了人们提出各种想法来克服耐药性和复发的问题——这几乎是靶向药物治疗失败的普遍原因。克服耐药性的一种广泛提出的方法是,不局限于对单一因果途径的短视关注,而是针对癌细胞基因调控网络中的多个节点。然而,大多数想法依赖于对网络的简单概念化:仅利用其拓扑结构,并将其视为因果相互作用的显示,而忽略了状态空间中的综合动态。在这里,我们回顾了更全面的全局网络动态形式框架,其中癌细胞与正常细胞类型一样,是高维吸引子状态。然后,治疗由网络扰动表示,该扰动将促进从这种癌细胞吸引子中退出并重新进入正常吸引子。在这个定性和易于理解的讨论中,我们展示了准势能景观的思想和最小作用量路径理论如何为计算需要协同靶向的网络节点(分子靶标)集提供新的形式理解,以便从癌细胞吸引子中退出。但是,基于“平均”癌细胞的网络配置来靶向癌细胞,无论多么精确,可能不足以消除所有肿瘤细胞,因为癌细胞群体的动态非遗传异质性使它们成为移动目标,并驱动具有生存能力、无反应性的细胞从相邻异常吸引子中补充癌细胞吸引子。

相似文献

1
How to escape the cancer attractor: rationale and limitations of multi-target drugs.如何逃离癌症吸引子:多靶点药物的原理和局限性。
Semin Cancer Biol. 2013 Aug;23(4):270-8. doi: 10.1016/j.semcancer.2013.06.003. Epub 2013 Jun 20.
2
Cancer-related networks: a help to understand, predict and change malignant transformation.癌症相关网络:理解、预测和改变恶性转化的帮手。
Semin Cancer Biol. 2013 Aug;23(4):209-12. doi: 10.1016/j.semcancer.2013.06.011. Epub 2013 Jul 2.
3
Multitargeted therapy: can promiscuity be praised in an era of political correctness?多靶点治疗:在政治正确的时代,滥交能受到赞扬吗? (注:这里“promiscuity”在医学语境外有“滥交”等含义,在医学文献翻译中需结合具体语境准确理解其在文中关于治疗靶点等方面的引申义,但仅按要求翻译此句就是上述内容 )
Crit Rev Oncol Hematol. 2006 Aug;59(2):150-8. doi: 10.1016/j.critrevonc.2006.01.005. Epub 2006 Jul 14.
4
Adaptation and learning of molecular networks as a description of cancer development at the systems-level: potential use in anti-cancer therapies.分子网络的适应和学习作为系统水平上癌症发展的描述:在抗癌治疗中的潜在应用。
Semin Cancer Biol. 2013 Aug;23(4):262-9. doi: 10.1016/j.semcancer.2013.06.005. Epub 2013 Jun 21.
5
On the intrinsic inevitability of cancer: from foetal to fatal attraction.论癌症的内在必然性:从胎儿到致命吸引。
Semin Cancer Biol. 2011 Jun;21(3):183-99. doi: 10.1016/j.semcancer.2011.05.003. Epub 2011 May 26.
6
Attractor landscape analysis of colorectal tumorigenesis and its reversion.结直肠癌发生及其逆转的吸引子景观分析
BMC Syst Biol. 2016 Oct 20;10(1):96. doi: 10.1186/s12918-016-0341-9.
7
Complex regulation of autophagy in cancer - integrated approaches to discover the networks that hold a double-edged sword.癌症中自噬的复杂调控——发现双刃剑网络的综合方法。
Semin Cancer Biol. 2013 Aug;23(4):252-61. doi: 10.1016/j.semcancer.2013.06.009. Epub 2013 Jun 28.
8
Genome network medicine: innovation to overcome huge challenges in cancer therapy.基因组网络医学:创新克服癌症治疗的巨大挑战。
Wiley Interdiscip Rev Syst Biol Med. 2014 Mar-Apr;6(2):201-8. doi: 10.1002/wsbm.1254. Epub 2013 Dec 6.
9
Vertical pathway targeting in cancer therapy.癌症治疗中的垂直通路靶向
Adv Pharmacol. 2012;65:1-26. doi: 10.1016/B978-0-12-397927-8.00001-4.
10
The biological framework: translational research from bench to clinic.生物学框架:从实验室到临床的转化研究。
Oncologist. 2010;15 Suppl 5:1-7. doi: 10.1634/theoncologist.2010-S5-01.

引用本文的文献

1
Understanding the role of toggle genes in chronic lymphocytic leukemia proliferation.了解切换基因在慢性淋巴细胞白血病增殖中的作用。
NPJ Syst Biol Appl. 2025 Aug 11;11(1):91. doi: 10.1038/s41540-025-00575-1.
2
Exploring Multi-Target Therapeutic Strategies for Glioblastoma via Endogenous Network Modeling.通过内源性网络建模探索胶质母细胞瘤的多靶点治疗策略
Int J Mol Sci. 2025 Apr 1;26(7):3283. doi: 10.3390/ijms26073283.
3
The Search for System's Parameters: Statistical and Dynamical Description from Complex Network Analysis.系统参数的探寻:复杂网络分析的统计和动力描述。
Methods Mol Biol. 2024;2745:21-30. doi: 10.1007/978-1-0716-3577-3_2.
4
Quantifying cancer cell plasticity with gene regulatory networks and single-cell dynamics.利用基因调控网络和单细胞动力学对癌细胞可塑性进行量化。
Front Netw Physiol. 2023 Sep 4;3:1225736. doi: 10.3389/fnetp.2023.1225736. eCollection 2023.
5
Challenges and Perspectives in Target Identification and Mechanism Illustration for Chinese Medicine.中药靶标识别与作用机制阐释的挑战与展望
Chin J Integr Med. 2023 Jul;29(7):644-654. doi: 10.1007/s11655-023-3629-9. Epub 2023 Feb 21.
6
Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution.休眠、干性和治疗抵抗:癌症进化中的相互关联的参与者。
Cancer Metastasis Rev. 2023 Mar;42(1):197-215. doi: 10.1007/s10555-023-10092-4. Epub 2023 Feb 9.
7
Cell Architecture-Dependent Constraints: Critical Safeguards to Carcinogenesis.细胞结构依赖性约束:致癌作用的关键保护机制。
Int J Mol Sci. 2022 Aug 3;23(15):8622. doi: 10.3390/ijms23158622.
8
Scales of Cancer Evolution: Selfish Genome or Cooperating Cells?癌症进化的尺度:自私的基因组还是协作的细胞?
Cancers (Basel). 2022 Jul 1;14(13):3253. doi: 10.3390/cancers14133253.
9
Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges.基于纳米的癌症治疗批准药物:现状与未来挑战。
Biomolecules. 2022 Jun 4;12(6):784. doi: 10.3390/biom12060784.
10
Tipping the Balance: A Criticality Perspective.扭转平衡:一种临界视角。
Entropy (Basel). 2022 Mar 14;24(3):405. doi: 10.3390/e24030405.